If you need more lookups,
subscriptions start at $34 USD/month.
Ryan Stansfield Location
San Diego, CA, US
Ryan Stansfield Work
Director @ (November 2022 - Present)
Associate Director @ (November 2019 - November 2022)
Senior Scientist @ Jecure Therapeutics (Jecure acquired by Genentech in 2018) (June 2017 - March 2019)
Senior Scientist @ Celgene Quanticel Research (Quanticel Pharmaceuticals acquired by Celgene in 201 (May 2012 - June 2017)
Senior Scientist @ (December 2006 - December 2011)
Scientist @ Schering-Plough Research Institute (NeoGenesis Pharmaceuticals acquired by SPRI (February 2002 - August 2006)
Chemistry and Biology Teacher @ (January 1998 - January 2000)
Ryan Stansfield Education
University of California, Santa Barbara 1993-1997
Ryan Stansfield Summary
Ryan Stansfield, based in San Diego, CA, US, is currently a Director at 858 Therapeutics. Ryan Stansfield brings experience from previous roles at 858 Therapeutics, Jecure Therapeutics (Jecure acquired by Genentech in 2018), Celgene Quanticel Research (Quanticel Pharmaceuticals acquired by Celgene in 201 and Cylene Pharmaceuticals. Ryan Stansfield holds a 1993 - 1997 University of California, Santa Barbara. Ryan Stansfield has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Ryan Stansfield?
Find contact details for 700 million professionals.